195
Views
45
CrossRef citations to date
0
Altmetric
Original Articles

Procalcitonin in acute myocardial infarction

, , , , , , , & show all
Pages 30-36 | Published online: 10 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Junru Dai, Bangbo Xia & Xiaomiao Wu. (2018) Elevated plasma procalcitonin level predicts poor prognosis of ST elevation myocardial infarction in Asian elderly. Scandinavian Journal of Clinical and Laboratory Investigation 78:1-2, pages 49-54.
Read now
Josef Yayan. (2013) Emerging families of biomarkers for coronary artery disease: inflammatory mediators. Vascular Health and Risk Management 9, pages 435-456.
Read now
Claudio Picariello, Chiara Lazzeri, Paola Attanà, Marco Chiostri, Gian Franco Gensini & Serafina Valente. (2012) The impact of admission procalcitonin on prognosis in acute coronary syndromes: a pilot study. Biomarkers 17:1, pages 56-61.
Read now
Claudio Picariello, Chiara Lazzeri, Serafina Valente, Marco Chiostri, Paola Attanà & Gian Franco Gensini. (2010) Kinetics of procalcitonin in cardiogenic shock and in septic shock. Preliminary data. Acute Cardiac Care 12:3, pages 96-101.
Read now
Dominic Kelly, Sohail Q. Khan, Onkar Dhillon, Paulene Quinn, Joachim Struck, Iain B. Squire, Joan E. Davies & Leong L. Ng. (2010) Procalcitonin as a prognostic marker in patients with acute myocardial infarction. Biomarkers 15:4, pages 325-331.
Read now

Articles from other publishers (40)

Muhammet Balcik, Salim Satar, Muge Gulen, Selen Acehan, Sarper Sevdimbas, Armagan Acele, Gonca Koksaldi Sahin, Cagdas Ince, Erdem Aksay & Ali Yuksek. (2023) BUN/albumin ratio predicts short-term mortality better than SYNTAX score in ST-elevation myocardial infarction patients. Journal of Cardiovascular Medicine 24:6, pages 326-333.
Crossref
Aongart Mahittikorn, Kwuntida Uthaisar Kotepui, Wanida Mala, Polrat Wilairatana & Manas Kotepui. (2022) Procalcitonin as a Candidate Biomarker for Malarial Infection and Severe Malaria: A Meta-Analysis. International Journal of Environmental Research and Public Health 19:18, pages 11389.
Crossref
Jing Hu, Changchun Yang, Guirong Yang, Huashuang Du, Haibin Zhao & Huiliang Liu. (2021) Effects of atorvastatin doses on serum level of procalcitonin and predictors for major adverse cardiovascular events in patients with acute myocardial infarction: a pilot study and post hoc analysis. Coronary Artery Disease 33:1, pages e87-e93.
Crossref
Yash Paul Sharma, Ganesh Kasinadhuni, Krishna Santosh, Nitin Kumar Parashar, Rakesh Sharma, Dinakar Bootla, Kewal Kanabar & Darshan Krishnappa. (2021) Prognostic role of procalcitonin in ST-elevation myocardial infarction complicated by cardiogenic shock. Asian Cardiovascular and Thoracic Annals 29:8, pages 751-757.
Crossref
Mustafa U Somuncu, Ahmet Avci, Belma Kalayci, Naile E Gudul, Fatih P Tatar, Ali R Demir, Murat Can & Ferit Akgul. (2021) Predicting long-term cardiovascular outcomes in myocardial infarction survivors using multiple biomarkers. Biomarkers in Medicine 15:11, pages 899-910.
Crossref
Yu HoriuchiNicholas Wettersten & Alan Maisel. (2021) Response by Horiuchi et al to Letter Regarding Article, “Biomarkers Enhance Discrimination and Prognosis of Type 2 Myocardial Infarction”. Circulation 143:8.
Crossref
Matthew Henwood, Daniel Lake, Felix Allen & Mansoor Sange. (2021) Myocarditis in SARS-CoV-2 negative patients with suspected preceding infection. BMJ Case Reports 14:1, pages e239513.
Crossref
Aleksey M. Chaulin & Dmitry V. Duplyakov. (2020) Biomarkers of acute myocardial infarction: diagnostic and prognostic value. Part 2 (Literature review). Journal of Clinical Practice 11:4, pages 70-82.
Crossref
Maria-Madălina Bostan, Cristian Stătescu, Larisa Anghel, Ionela-Lăcrămioara Șerban, Elena Cojocaru & Radu Sascău. (2020) Post-Myocardial Infarction Ventricular Remodeling Biomarkers—The Key Link between Pathophysiology and Clinic. Biomolecules 10:11, pages 1587.
Crossref
Oliwia Grzegorowska & Jacek Lorkowski. (2020) Possible Correlations between Atherosclerosis, Acute Coronary Syndromes and COVID-19. Journal of Clinical Medicine 9:11, pages 3746.
Crossref
Yu Horiuchi, Nicholas Wettersten, Mitul P. Patel, Christian Mueller, Sean-Xavier Neath, Robert H. Christenson, Nils G. Morgenthaler, James McCord, Richard M. Nowak, Gary M. Vilke, Lori B. Daniels, Judd E. Hollander, Fred S. Apple, Chad M. Cannon, John T. Nagurney, Donald Schreiber, Christopher deFilippi, Christopher Hogan, Deborah B. Diercks, Gary Headden, Alexander T. Limkakeng, Inder Anand, Alan H.B. Wu, Stefan Ebmeyer, Allan S. Jaffe, W. Frank Peacock & Alan S. Maisel. (2020) Biomarkers Enhance Discrimination and Prognosis of Type 2 Myocardial Infarction. Circulation.
Crossref
Ajete Aliu-Bejta, Anita Atelj, Mentor Kurshumliu, Shemsedin Dreshaj & Bruno Baršić. (2020) Presepsin values as markers of severity of sepsis. International Journal of Infectious Diseases 95, pages 1-7.
Crossref
Martin Reindl, Christina Tiller, Magdalena Holzknecht, Ivan Lechner, Benjamin Henninger, Agnes Mayr, Christoph Brenner, Gert Klug, Axel Bauer, Bernhard Metzler & Sebastian J. Reinstadler. (2020) Association of Myocardial Injury With Serum Procalcitonin Levels in Patients With ST-Elevation Myocardial Infarction. JAMA Network Open 3:6, pages e207030.
Crossref
Андрей Анатольевич Бобылев, Светлана Александровна Рачина, Сергей Николаевич Авдеев & Роман Сергеевич Козлов. (2020) ДИАГНОСТИКА ВНЕБОЛЬНИЧНОЙ ПНЕВМОНИИ У ЛИЦ С ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТЬЮ: ОБЗОР ЛИТЕРАТУРЫ И РЕЗУЛЬТАТЫ СОБСТВЕННЫХ ИССЛЕДОВАНИЙ, "Вестник Центрального научно-исследовательского института туберкулеза". Вестник ЦНИИТ:2, pages 7-21.
Crossref
A. A. Bobylev, S. A. Rachina, S. N. Avdeev & R. S. Kozlov. (2019) Community-acquired pneumonia in patients with chronic heart failure: clinical manifestation and a diagnostic role of biomarkers. Russian Pulmonology 29:4, pages 391-402.
Crossref
Ramazan Asoğlu, Hakan Kaya, Emin Asoğlu, Abdülmecid Afşin & Arif Süner. (2019) Prokalsitonin Düzeyleri ile Koroner Yavaş Akım Arasındaki İlişki.. Adıyaman Üniversitesi Sağlık Bilimleri Dergisi.
Crossref
Yuqi Chen, Yifei Tao, Lan Zhang, Weiting Xu & Xiang Zhou. (2019) Diagnostic and prognostic value of biomarkers in acute myocardial infarction. Postgraduate Medical Journal 95:1122, pages 210-216.
Crossref
Seyed-Vahid Hashemipour, Hamidreza Pourhosseini & Ali Hosseinsabet. (2019) Correlation between the serum procalcitonin level and the extension and severity of coronary artery disease in patients with non-ST-segment elevation myocardial infarction. Cardiovascular Endocrinology & Metabolism 8:2, pages 62-66.
Crossref
Itzhak Vitkon-Barkay, Tsilia Lazarovitch, Dror Marchaim, Ronit Zaidenstein, Elizabeth Temkin, Emily T. Martin, Hannah E. Segaloff, Ilya Litovchik, Victoria Rum, Chana Richter, Oran Tzuman, Zvi Vered & Saar Minha. (2018) Usefulness of Serum Procalcitonin as a Markerfor Coexisting Infection in Patients With Acute Myocardial Infarction. The American Journal of Cardiology 122:5, pages 729-734.
Crossref
David N. Gilbert. (2017) Role of Procalcitonin in the Management of Infected Patients in the Intensive Care Unit. Infectious Disease Clinics of North America 31:3, pages 435-453.
Crossref
S. Koerdt, N. Rommel, N.H. Rohleder, S. Sandig, G. Frohwitter, T. Steiner, K.D. Wolff & M.R. Kesting. (2017) Perioperative serum levels of procalcitonin, C-reactive protein, and leukocytes in head and neck free flaps. International Journal of Oral and Maxillofacial Surgery 46:6, pages 699-705.
Crossref
Ahmet Göktuğ Ertem, Tolga Han Efe, Çağrı Yayla, Mehmet Kadri Akboğa, Burak Açar, Sefa Ünal, Özgür Kirbaş, Yasemin Sezer Tekce, Orhan Maden, Hatice Selcuk & Mehmet Timur Selcuk. (2016) The Association Between Serum Procalcitonin Levels and Severity of Coronary Artery Disease Assessed by SYNTAX Score in Patients With Acute Coronary Syndrome. Angiology 68:1, pages 40-45.
Crossref
Sani N. Murat, Alparslan Kurtul, Ibrahim E. Celik, Mustafa Duran, Mikail Yarlioglues, Alparslan Kilic & Deniz Elcik. (2016) The association of serum procalcitonin level with the no-reflow phenomenon after a primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction. Coronary Artery Disease 27:2, pages 116-121.
Crossref
Alparslan Kurtul, Sani Namik Murat, Mikail Yarlioglues, Mustafa Duran, Adil Hakan Ocek, Ibrahim Etem Celik, Alparslan Kilic, Cemal Koseoglu, Fatih Oksuz & Veysel Ozgur Baris. (2015) Procalcitonin as an Early Predictor of Contrast-Induced Acute Kidney Injury in Patients With Acute Coronary Syndromes Who Underwent Percutaneous Coronary Intervention. Angiology 66:10, pages 957-963.
Crossref
Gaku Takahashi, Shigehiro Shibata, Hiroyasu Ishikura, Masanao Miura, Yasuo Fukui, Yoshihiro Inoue & Shigeatsu Endo. (2015) Presepsin in the prognosis of infectious diseases and diagnosis of infectious disseminated intravascular coagulation. European Journal of Anaesthesiology 32:3, pages 199-206.
Crossref
George Tsaknis, Iraklis Tsangaris, Ignatios Ikonomidis & Argirios Tsantes. (2014) Clinical Usefulness of Novel Serum and Imaging Biomarkers in Risk Stratification of Patients with Stable Angina. Disease Markers 2014, pages 1-14.
Crossref
Claudio Picariello, Chiara Lazzeri, Paola Attanà, Marco Chiostri, Gian Franco Gensini & Serafina Valente. (2013) Procalcitonin as a Reliable Biomarker in Acute Coronary Syndromes: What Is Its Role?. The Journal of Emergency Medicine 45:6, pages 921-922.
Crossref
Sally J. Aldous. (2013) Cardiac biomarkers in acute myocardial infarction. International Journal of Cardiology 164:3, pages 282-294.
Crossref
S. Bode-Jänisch, S. Schütz, A. Schmidt, T. Tschernig, A.S. Debertin, A. Fieguth, L. Hagemeier, J. Teske, S. Suerbaum, M. Klintschar & F.C. Bange. (2013) Serum procalcitonin levels in the postmortem diagnosis of sepsis. Forensic Science International 226:1-3, pages 266-272.
Crossref
A. Schiopu, B. Hedblad, G. Engström, J. Struck, N. G. Morgenthaler & O. Melander. (2012) Plasma procalcitonin and the risk of cardiovascular events and death: a prospective population‐based study. Journal of Internal Medicine 272:5, pages 484-491.
Crossref
Alan S. Maisel & Rajiv Choudhary. (2012) Biomarkers in acute heart failure—state of the art. Nature Reviews Cardiology 9:8, pages 478-490.
Crossref
Ren? P Andri?Ulrich M Becher, Ricarda Frommold, Vedat Tiyerili, Jan W Schrickel, Georg Nickenig & J?rg O Schwab. (2012) Interleukin-6 is the strongest predictor of 30-day mortality in patients with cardiogenic shock due to myocardial infarction. Critical Care 16:4, pages R152.
Crossref
Firat Bektas, Secgin Soyuncu, Ilker Gunduz, Ibrahim Basarici, Halide Akbas & Cenker Eken. (2011) The Value of Procalcitonin, a Novel Inflammatory Marker, in?the?Diagnosis of Myocardial Infarction and Evaluation of Acute Coronary Syndrome Patients. The Journal of Emergency Medicine 41:5, pages 524-530.
Crossref
Claudio Picariello, Chiara Lazzeri, Serafina Valente, Marco Chiostri & Gian Franco Gensini. (2010) Procalcitonin in acute cardiac patients. Internal and Emergency Medicine 6:3, pages 245-252.
Crossref
Tunay Sentürk. (2011) Measurement of Procalcitonin in Acute Coronary Syndrome. Circulation Journal 75:5, pages 1059-1060.
Crossref
Christoph R. Sinning, Jan-Malte Sinning, Andreas Schulz, Renate B. Schnabel, Edith Lubos, Philipp S. Wild, Jana Papassotiriou, Andreas Bergmann, Stefan Blankenberg, Thomas Munzel & Christoph Bickel. (2011) Association of Serum Procalcitonin With Cardiovascular Prognosis in Coronary Artery Disease. Circulation Journal 75:5, pages 1184-1191.
Crossref
Vicente F Corrales-Medina, Mohammad Madjid & Daniel M Musher. (2010) Role of acute infection in triggering acute coronary syndromes. The Lancet Infectious Diseases 10:2, pages 83-92.
Crossref
Michaela Semeraro, Caroline Thomée, Estelle Rolland, Marie Cecile Le Deley, David Rosselini, Frederic Troalen, Loredana Amoroso, Marie Dubrel & Olivier Hartmann. (2010) A predictor of unfavourable outcome in neutropenic paediatric patients presenting with fever of unknown origin. Pediatric Blood & Cancer 54:2, pages 284-290.
Crossref
Luigi M. Biasucci, Gina Biasillo & Antonella Stefanelli. (2009) Procalcitonin and acute coronary syndromes: a new biomarker for an old disease. Internal and Emergency Medicine 4:5, pages 363-365.
Crossref
Claudio Picariello, Chiara Lazzeri, Marco Chiostri, Gianfranco Gensini & Serafina Valente. (2009) Procalcitonin in patients with acute coronary syndromes and cardiogenic shock submitted to percutaneous coronary intervention. Internal and Emergency Medicine 4:5, pages 403-408.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.